A Multi-Centered, Randomized, Double-Blind, Placebo Controlled Study Assessing the Add-on Effect of Oral Steroids in Relapsing Remitting Multiple Sclerosis Subjects Treated With Glatiramer Acetate (GA).

Trial Profile

A Multi-Centered, Randomized, Double-Blind, Placebo Controlled Study Assessing the Add-on Effect of Oral Steroids in Relapsing Remitting Multiple Sclerosis Subjects Treated With Glatiramer Acetate (GA).

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 09 Jan 2014

At a glance

  • Drugs Glatiramer acetate (Primary) ; Prednisone
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms ASSERT
  • Sponsors Teva Neuroscience
  • Most Recent Events

    • 06 Oct 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 01 Apr 2009 Actual number of patients (414) added, trial sponsor changed from Teva Neuroscience to Teva Pharmaceutical Industries as reported by ClinicalTrials.gov
    • 01 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top